CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma

References

• Chidambaranathan-Reghupaty, S., Fisher, P. B., & Sarkar, D. (2021). Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in Cancer Research, 149, 1–61. https://doi.org/10.1016/bs.acr.2020.10.001
   PubMed Web of Science ®Google Scholar
• D’Souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020). Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology, 26(38), 5759–5783. https://doi.org/10.3748/wjg.v26.i38.5759
   PubMed Web of Science ®Google Scholar
• Dai, L., Zhao, T., Bisteau, X., Sun, W., Prabhu, N., Lim, Y. T., Sobota, R. M., Kaldis, P., & Nordlund, P. (2018). Modulation of protein-interaction states through the cellcycle. Cell, 173(6), 1481–1494. https://doi.org/10.1016/j.cell.2018.03.065
   PubMed Web of Science ®Google Scholar
• Doncheva, N. T., Morris, J. H., Gorodkin, J., & Jensen, L. J. (2019). Cytoscape StringApp: Network analysis and visualization of proteomics data. Journal of Proteome Research, 18(2), 623–632. https://doi.org/10.1021/acs.jproteome.8b00702
   PubMed Web of Science ®Google Scholar
• Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–386. https://doi.org/10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Gill, R. M., Gabor, T. V., Couzens, A. L., & Scheid, M. P. (2013). The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation. Molecular and Cellular Biology, 33(3), 498–513. https://doi.org/10.1128/MCB.00276-12
   PubMed Web of Science ®Google Scholar
• Goshima, G., & Kimura, A. (2010). New look inside the spindle: Microtubule-dependent microtubule generation within the spindle. Current Opinion in Cell Biology, 22(1), 44–49. https://doi.org/10.1016/j.ceb.2009.11.012
   PubMed Web of Science ®Google Scholar
• Goto, Y., Hayashi, R., Muramatsu, T., Ogawa, H., Eguchi, I., Oshida, Y., Ohtani, K., & Yoshida, K. (2006). JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. Biochimica et biophysica acta, 1759(1–2), 60–68. https://doi.org/10.1016/j.bbaexp.2006.02.004
   PubMedGoogle Scholar
• Guo, Y., Zhou, K., Zhuang, X., Li, J., & Shen, X. (2021). CDCA7-regulated inflammatory mechanism through TLR4/NF-kappaB signaling pathway in stomach adenocarcinoma. Biofactors, 47(5), 865–878. https://doi.org/10.1002/biof.1773
   PubMed Web of Science ®Google Scholar
• Jimenez-P, R., Martin-Cortazar, C., Kourani, O., Chiodo, Y., Cordoba, R., Dominguez-Franjo, M. P., Redondo, J. M., Iglesias, T., & Campanero, M. R. (2018). CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth. Haematologica, 103(10), 1669–1678. https://doi.org/10.3324/haematol.2018.188961
   PubMed Web of Science ®Google Scholar
• Lacroix, B., & Dumont, J. (2022). Spatial and temporal scaling of microtubules and mitotic spindles. Cells, 11(2), 248. https://doi.org/10.3390/cells11020248
   PubMed Web of Science ®Google Scholar
• Li, S., Huang, J., Qin, M., Zhang, J., & Liao, C. (2020). High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer. Molecular Medicine Reports, 22(1), 57–66. https://doi.org/10.3892/mmr.2020.11089
   PubMed Web of Science ®Google Scholar
• Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48(W1), W509–514. https://doi.org/10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Liu, S., Wang, Y., Miao, C., Xing, Q., & Wang, Z. (2021). High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity. Cancer Cell International, 21(1), 140. https://doi.org/10.1186/s12935-021-01834-x
   PubMed Web of Science ®Google Scholar
• McGlynn, K. A., Petrick, J. L., & El-Serag, H. B. (2021). Epidemiology of hepatocellularcarcinoma. Hepatology, 73 Suppl 1(Suppl 1), 4–13. https://doi.org/10.1002/hep.31288
   PubMedGoogle Scholar
• Moon, H., Park, H., & Ro, S. W. (2021). C-Myc-driven hepatocarcinogenesis. Anticancer Research, 41(10), 4937–4946. https://doi.org/10.21873/anticanres.15307
   PubMed Web of Science ®Google Scholar
• Osthus, R. C., Karim, B., Prescott, J. E., Smith, B. D., McDevitt, M., Huso, D. L., & Dang, C. V. (2005). The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. Cancer Research, 65(13), 5620–5627. https://doi.org/10.1158/0008-5472.CAN-05-0536
   PubMed Web of Science ®Google Scholar
• Prescott, J. E., Osthus, R. C., Lee, L. A., Lewis, B. C., Shim, H., Barrett, J. F., Guo, Q., Hawkins, A. L., Griffin, C. A., & Dang, C. V. (2001). A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation. Journal of Biological Chemistry, 276(51), 48276–48284. https://doi.org/10.1074/jbc.M107357200
   PubMed Web of Science ®Google Scholar
• Sinha, D., Duijf, P., & Khanna, K. K. (2019). Mitotic slippage: An old tale with a new twist. Cell Cycle, 18(1), 7–15. https://doi.org/10.1080/15384101.2018.1559557
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., Jensen, L. J., & von Mering, C. (2021). The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research, 49(D1), D605–612. https://doi.org/10.1093/nar/gkaa1074
   PubMed Web of Science ®Google Scholar
• Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2018). LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Research, 46(D1), D956–963. https://doi.org/10.1093/nar/gkx1090
   PubMed Web of Science ®Google Scholar
• Wang, H., Ye, L., Xing, Z., Li, H., Lv, T., Liu, H., Zhang, F., & Song, Y. (2019). CDCA7 promotes lung adenocarcinoma proliferation via regulating the cell cycle. Pathology, Research and Practice, 215(11), 152559. https://doi.org/10.1016/j.prp.2019.152559
   PubMed Web of Science ®Google Scholar
• Wu, P., Heins, Z. J., Muller, J. T., Katsnelson, L., de Bruijn, I., Abeshouse, A. A., Schultz, N., Fenyo, D., & Gao, J. (2019). Integration and analysis of CPTAC proteomics data in the context of cancer genomics in the cBioportal. Molecular & Cellular Proteomics, 18(9), 1893–1898. https://doi.org/10.1074/mcp.TIR119.001673
   PubMed Web of Science ®Google Scholar
• Ye, L., Li, F., Song, Y., Yu, D., Xiong, Z., Li, Y., Shi, T., Yuan, Z., Lin, C., Wu, X., Ren, L., Li, X., & Song, L. (2018). Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer. International Journal of Cancer, 143(10), 2602–2613. https://doi.org/10.1002/ijc.31766
   PubMed Web of Science ®Google Scholar
• Zhang, W., Qiu, X., Sun, D., Zhang, D., Qi, Y., Li, X., Liu, B., Liu, J., & Lin, B. (2020). Systematic analysis of the clinical relevance of cell division cycle associated family in endometrial carcinoma. Journal of Cancer, 11(19), 5588–5600. https://doi.org/10.7150/jca.46324
   PubMed Web of Science ®Google Scholar